Public Company News
WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic
WUXI, China, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 (DP5) and Drug Product Packaging Center (DPPC) – have r...
2026-01-13 11:07
5321
WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic
WUXI, China, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 (DP5) and Drug Product Packaging Center (DPPC) – have r...
2026-01-13 11:07
7680
SMAR Investors Have Opportunity to LeadSmartsheet Inc. Securities Lawsuit
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds all former stockholders of Smartsheet Inc. (NYSE: SMAR) in connection with the January 2025 sale (the "Merger" or "Buyout") of Smartsheet to affiliates of investment funds managed by affilia...
2026-01-13 10:00
3807
Vistra Prices Private Offering of $2.250 Billion of Senior Secured Notes
IRVING, Texas, Jan. 12, 2026 /PRNewswire/ -- Vistra Corp. (NYSE: VST) (the "Company" or "Vistra") announced today the pricing of a private offering (the "Offering") of $2.25 billion aggregate principal amount of senior secured notes, consisting of $1.0 billion aggregate principal amount of senior...
2026-01-13 09:49
2888
SMAR INVESTOR ALERT: Former Smartsheet Inc. Shareholders with Substantial Holdings Have Opportunity to Lead the Smartsheet Class Action Lawsuit
SAN DIEGO, Jan. 12, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP
2026-01-13 09:33
3157
BTDR Investors Have Opportunity to LeadBitdeer Technologies Group Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6, 2024 and November 10, 2025, both dates inclusive (the "Class Period"), of the important February 2, 202...
2026-01-13 09:00
3792
Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announcedtoday that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent small-molecule colony-...
2026-01-13 08:54
4829
Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announcedtoday that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent small-molecule colony-...
2026-01-13 08:54
2870
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Varonis Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -VRNS
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the "...
2026-01-13 08:32
2316
MISSION BANK OPENS NEW OFFICE IN NORTH SAN LUIS OBISPO COUNTY
BAKERSFIELD, Calif., Jan. 12, 2026 /PRNewswire/ -- Mission Bank has expanded existing operations in the Central Coast with the addition of a Loan and Deposit Production team located in North San Luis Obispo County. Led by Mark Pearce, and joined by Relationship Managers Sarah Kramer and Katie ...
2026-01-13 08:28
2543
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans
* AbbVie will provide low prices in Medicaid, and expand affordable, direct-to-patient offerings for treatments used by millions of Americans through TrumpRx * AbbVie will commit $100 billion in U.S. research and development (R&D) and capital investments, including manufacturing, over the nex...
2026-01-13 07:30
2629
Secretary of War Visits Lockheed Martin F-35 Production Facility
FORT WORTH, Texas, Jan. 12, 2026 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) welcomed Secretary of War Pete Hegseth to the Fort Worth, Texas, F-35 Lightning II production facility today. The visit was part of the secretary's Arsenal of Freedom industry tour and underscored Lockheed Martin's role ...
2026-01-13 06:43
2365
DEFT Investors Have Opportunity to Lead DeFi Technologies, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofDeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the "Class Period"), of the important January 30, 2026 lea...
2026-01-13 06:41
2406
KLAR INVESTOR ALERT: Hagens Berman Notifies Klarna Group plc (KLAR) Investors of Feb. 20 Deadline in IPO Securities Class Action
SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors inKlarna Group plc (NYSE: KLAR) of the upcomingFebruary 20, 2026, lead plaintiff deadline in a pending securities class action. The firm is actively investigating the lawsuits cl...
2026-01-13 06:41
2359
PRGO Deadline: PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead...
2026-01-13 06:40
2355
Datasea Announces Major Acoustic Technology Advancements in Brain-Computer Interface Applications
Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market BEIJING, Jan. 12, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in aco...
2026-01-12 22:30
2516
PlayNitride and Brillink Announce Strategic Collaboration to Advance Array-Based Photonic Interconnects
HSINCHU and MIAOLI, Jan. 12, 2026 /PRNewswire/ -- PlayNitride, a global leader in MicroLED technologies, today announced a strategic collaboration with Brillink to develop a next-generation array-based photonic interconnect solution designed to deliver longer reach, lower power consumption, and ...
2026-01-12 22:00
370
Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of Inflammatory Bowel Disease
CAMBRIDGE, Mass., Jan. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"),
a clinical-stage, generative AI-driven drug discovery company, today announced
the completion of first patient first dose in BETHESDA: a Phase IIa clinical
trial of ISM5411 (NCT07265570
2026-01-12 21:30
1606
WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufactur...
2026-01-12 21:09
5328
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, and Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveragin...
2026-01-12 21:05
4249
Week's Top Stories
Most Reposted
MTR Lab and ZGC Science City Ltd Establish Ecosystem Partnership
[Picked up by 310 media titles]
2026-03-18 12:00
Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 308 media titles]
2026-03-24 14:00HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 306 media titles]
2026-03-20 09:36
Beijing InfoComm China 2026 Conference Lineup Presents Future of AI in Tech Aligning with the Nation's Next Strategic Five-Year Plan
[Picked up by 298 media titles]
2026-03-18 08:00
MetaOptics progresses on its strategic growth and leadership transition initiatives
[Picked up by 283 media titles]
2026-03-20 08:15Most Read
H World Group Reports Strong Full-Year 2025 Results, Driven by Asset-light Growth
2026-03-18 21:05
7457
Everbright Environment Announces 2025 Annual Results
2026-03-20 23:14
7272
Ten Pao Group Announces 2025 Annual Results
2026-03-20 23:35
7108
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
2026-03-21 04:05
7027